153710 — Optipharm Co Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩90bn
- KR₩87bn
- KR₩17bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -655 | -2,352 | -3,080 | -2,045 | -2,437 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -39.1 | -679 | -1,181 | -1,326 | 65.6 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 285 | 430 | 1,215 | -184 | -785 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 447 | -1,617 | -1,969 | -2,434 | -1,723 |
Capital Expenditures | -755 | -955 | -757 | -4,604 | -1,737 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -5,201 | -3,002 | -6,630 | 2,665 | -1,852 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -5,956 | -3,956 | -7,387 | -1,939 | -3,589 |
Financing Cash Flow Items | -109 | -135 | -156 | -130 | -147 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -584 | 1,106 | 1,819 | 1,760 | 1,993 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -6,093 | -4,467 | -7,538 | -2,613 | -3,319 |